(NASDAQ: TIL) Instil Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.57%.
Instil Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast TIL's revenue for 2029 to be $352,924,073, with the lowest TIL revenue forecast at $352,924,073, and the highest TIL revenue forecast at $352,924,073. On average, 1 Wall Street analysts forecast TIL's revenue for 2030 to be $1,018,756,663, with the lowest TIL revenue forecast at $1,018,756,663, and the highest TIL revenue forecast at $1,018,756,663.
In 2031, TIL is forecast to generate $1,820,379,743 in revenue, with the lowest revenue forecast at $1,820,379,743 and the highest revenue forecast at $1,820,379,743.